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Abstract
Background: An important step in the reconstruction of a metabolic network is annotation of metabolites.
Metabolites are generally annotated with various database or structure based identifiers. Metabolite annotations in
metabolic reconstructions may be incorrect or incomplete and thus need to be updated prior to their use.
Genome-scale metabolic reconstructions generally include hundreds of metabolites. Manually updating annotations
is therefore highly laborious. This prompted us to look for open-source software applications that could facilitate
automatic updating of annotations by mapping between available metabolite identifiers. We identified three
applications developed for the metabolomics and chemical informatics communities as potential solutions. The
applications were MetMask, the Chemical Translation System, and UniChem. The first implements a “metabolite
masking” strategy for mapping between identifiers whereas the latter two implement different versions of an InChI
based strategy. Here we evaluated the suitability of these applications for the task of mapping between metabolite
identifiers in genome-scale metabolic reconstructions. We applied the best suited application to updating identifiers
in Recon 2, the latest reconstruction of human metabolism.
Results: All three applications enabled partially automatic updating of metabolite identifiers, but significant manual
effort was still required to fully update identifiers. We were able to reduce this manual effort by searching for new
identifiers using multiple types of information about metabolites. When multiple types of information were
combined, the Chemical Translation System enabled us to update over 3,500 metabolite identifiers in Recon 2. All but
approximately 200 identifiers were updated automatically.
Conclusions: We found that an InChI based application such as the Chemical Translation System was better suited
to the task of mapping between metabolite identifiers in genome-scale metabolic reconstructions. We identified
several features, however, that could be added to such an application in order to tailor it to this task.
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Background
Metabolic network reconstructions are knowledge bases
of key components in the metabolic reaction network of
a particular organism or cell type [1,2]. Reconstructions
vary in size from small-scale reconstructions where only
a few pathways of interest are included, to genome-scale
reconstructions where the aim is to include all known
components in a network. The components of a metabolic
network reconstruction are the metabolic reactions in the
network, the metabolites that participate in those reac-
tions, the enzymes that catalyze the reactions, and the
genes that encode those enzymes. Individual components
are linked with mathematical structures that enable com-
putational analysis of the network as an integrated system.
Computational analysis of genome-scale metabolic recon-
structions has, for example, been used for biochemical
[3,4], biomedical [5-7], and bioengineering [8,9] purposes.
An important step in the reconstruction of a metabolic
network is the annotation of reconstruction compo-
nents [2]. The identities and functions of components
included in metabolic network reconstructions are gen-
erally known. Annotation here refers to the process of
attaching various metadata for components to a recon-
struction. These annotations serve to unambiguously
identify components and enable efficient mapping of
data to the reconstruction for analysis. Components are
generally annotated with an appropriate type of identi-
fier, e.g., an Entrez gene ID for genes and an Enzyme
Classification (EC) number for enzymes. Metabolites are
usually annotated with several types of identifiers. A com-
prehensive protocol for genome-scale metabolic recon-
struction [2] recommended annotating metabolites with
a primary identifier in at least one of the following
three databases: ChEBI [10], KEGG Compound [11,12],
or PubChem Compound [13]. The protocol also rec-
ommended annotating metabolites with structure-based
identifiers, such as the IUPAC International Chemical
Identifier (InChI) and the Simplified Molecular-Input
Line-Entry System (SMILES). We add that further anno-
tation with primary identifiers in databases that are spe-
cific to the reconstructed organism is also advisable, e.g.,
the Human Metabolome Database (HMDB) [14,15] for
human metabolic reconstructions.
Database identifiers have the advantage of providing
direct links to data that are stored in each database.
Data types that can be mapped to the reconstruction
via metabolite identifiers include physicochemical data,
metabolomics data, metabolic pathways and metabo-
lite structures. Different types of data are available
in each database. Whereas KEGG has more data on
metabolic genes, enzymes and reactions, HMDB provides
more information on metabolites. Since not all chemical
databases provide cross-references to all other databases,
it is usually not enough to annotate metabolites with only
one type of identifier. Instead they should be annotated
with identifiers in as many relevant databases as possible.
Multiple annotations also aid in identification since any
one database may not contain all metabolites in a given
reconstruction.
Advantages of structure-based identifiers are that they
are unambiguous and database independent. InChIs and
SMILES strings can also be converted to metabolite struc-
tures that can be used directly for various computational
analyses [16-19]. Although SMILES strings have a sim-
pler syntax and are more human readable, InChIs are
preferable in many ways [20]. Firstly, they have a lay-
ered structure that makes them highly flexible and easy to
manipulate. Secondly, they can account for tautomerism.
Multiple tautomers of the same compound can be repre-
sented with the same standardized or “standard” InChI.
Alternatively, a specific tautomer can be represented with
a nonstandard InChI. A third advantage of InChIs is that
the InChI algorithm in non-propriatory and is imple-
mented in open source software. Version 1 of the InChI is
currently in use.
A disadvantage of the InChI is that its length increases
with molecular size and level of structural detail. Also, it
includes non-alphabetical characters such as /, \, - and +.
These features make the InChI inconvenient for inter-
net and database searches [20]. A hashed version, the
InChIKey, was therefore created [20]. The InChIKey has
a fixed length of 27 characters, and only includes upper-
case English letters and dashes. These features also make
it a good choice as a database independent identifier for
metabolites in metabolic reconstructions. Most chemical
databases now include an InChIKey (as well as an InChI
and SMILES string) in each database entry. The hashing
algorithm that generates InChIKeys from InChIs is not
reversible [20], meaning that there is no algorithm that
can convert an InChIKey back to an InChI. InChIKeys are
therefore not directly convertible to metabolite structure.
To retrieve an InChI from an InChIKey it is necessary to
use a lookup table or a chemical structure resolver such as
the Chemical Identifier Resolver [21] or ChemSpider [22].
Genome-scale reconstructions usually include hun-
dreds of metabolites. The latest human reconstruction,
Recon 2, includes over 2500 metabolites [23]. Manual
annotation of such a large number of metabolites, with
multiple identifiers each, is extremely laborious. Metabo-
lites in early reconstructions were generally annotated
manually. Today, reconstruction tools such as the Model
SEED [24], rBioNet [25] and the SuBliMinaL Toolbox
[26] facilitate the process by populating new recon-
structions with pre-annotated components from source
databases. Metabolites in the source databases, however,
may have incomplete or incorrect annotations, which
will then be propagated to all new reconstructions.
Metabolites in existing reconstructions may likewise have
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incomplete or incorrect annotations. Metabolite annota-
tions in metabolic reconstructions may therefore need to
be updated prior to their use. Software applications that
enable automatic updating of annotations are desirable.
The SuBliMinaL Toolbox comes with an annotation
module that can be used to retrieve ChEBI identifiers
for metabolites by searching the ChEBI database with
metabolite names. A recently published annotation tool
called Metingear [27] also features a name search for
database identifiers, but against multiple databases. In
our experience, metabolite names are poor identifiers.
Most metabolites have several synonyms and databases
differ in the use of those synonyms. Searching a database
with a metabolite name may therefore yield no results if
the metabolite is registered under a different synonym.
The same name is also often associated with multiple
stereoisomers of the same compound, across different
databases and within the same database. The name dex-
trose, for example, is associated with four entries in
PubChem Compound: D-glucose (PubChem Compound
ID (CID) 5793), α-D-glucose (PubChem CID 79025), β-
D-glucose (PubChem CID 64689) and a generic hexopy-
ranose (PubChem CID 206). As the last entry (PubChem
CID 206) demonstrates, names are also sometimes asso-
ciated with the incorrect structures. Numerous other
examples of incorrect associations between names and
structures are given in [28]. A name search can therefore
yield a list of several candidate identifiers that must be
sorted through manually to find the one that best matches
the target compound. It is therefore not conducive to
automatic updating of identifiers.
A name search is the best option available for updat-
ing identifiers for metabolites that are only annotated with
a name. However, most metabolites in source databases
for metabolic reconstruction tools are annotated with
at least one identifier besides name. The same goes
for metabolites in existing metabolic reconstructions,
especially those that were built according to the afore-
mentioned protocol [2]. The non-name identifiers are
generally more specific than names as they refer to spe-
cific structures or database entries. Software applications
that enable mapping between non-name identifiers could
therefore facilitate automatic updating of metabolite iden-
tifiers in metabolic network reconstructions.
The problem of annotating large sets of metabolites
is well known in metabolomics and chemical informat-
ics. Applications that can be used to partially automate
annotation have been developed for these fields. We
searched among these for applications that were suitable
for mapping between metabolite identifiers in metabolic
reconstructions. We only considered open-source appli-
cations as these can readily be adapted to the needs of
the metabolic reconstruction community and integrated
into metabolic reconstruction tools. Three applications
that met these criteria were MetMask [29], the Chem-
ical Translation System (CTS) [30] and UniChem [31].
These applications implement annotation strategies that
go beyond name search. They enable mapping between
multiple types of identifiers, including chemical names.
Different annotation strategies are implemented in each
of the three applications. Here, we compare these appli-
cations, to determine which annotation strategy is best
suited for annotation of metabolites in genome scale
metabolic reconstructions. We then apply the top appli-
cation to update annotations of metabolites in the latest
human reconstruction Recon 2 [23].
Applications
MetMask
MetMask [29] is a desktop application for creating and
querying custom local databases of identifier groups
or “metabolite masks”. Identifier groups from multiple
sources, such as public databases and private chemi-
cal libraries, can be imported into the same MetMask
database. We imported identifier groups from Recon 2,
HMDB and ChEBI. MetMask merges groups that are
deemed compatible by the applications heuristics. A Met-
Mask database can be queried with an identifier of one
type (e.g., synonym) to find other identifiers of either the
same or a different type (e.g., InChIKey) that belong to the
same mask. Metmask is available from http://metmask.
sourceforge.net/.
The Chemical Translation System
CTS [30] is a web application for mapping between
chemical identifiers. It covers 215 types of identifiers,
including chemical names, structure-based identifiers,
and database identifiers. Queries are sent to a single
database where data from multiple external databases has
been aggregated. Identifiers are matched based on “stan-
dard” InChIKeys, which are generated from “standard”
InChIs, i.e., InChIs produced with standard options set-
tings. Standard InChIs and InChIKeys are not tautomer
specific. CTS finds all standard InChIKeys that are linked
to an input identifier and returns all identifiers of the
requested output type(s) that are linked to the same stan-
dard InChIKeys.Web services and a web user interface for
CTS are available at http://cts.fiehnlab.ucdavis.edu.
UniChem
UniChem [31] is a web application that was designed
for automatic generation of cross-references between dif-
ferent databases, but can also be used to map between
chemical identifiers. It is similar to CTS in that identifiers
are matched based on standard InChIs and InChIKeys.
Queries to UniChem are also sent to a single database
where data from multiple external databases has been
aggregated.
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There are two major differences between UniChem and
CTS that are relevant to metabolite annotation. The first
is that UniChem covers a much lower number of iden-
tifier types. At the time of writing, it covered identifiers
in 18 public databases in addition to standard InChIs
and InChIKeys. Covered databases included KEGG Com-
pound, ChEBI and HMDB, but not PubChem Compound.
Chemical names were not covered. The second major dif-
ference between UniChem and CTS is that data from
external databasesmust pass various quality checks before
they are imported into the UniChem database. External
database entries are generally required to include at least
a database identifier and a standard InChI to be included
in the UniChem database. The quality checks performed
by UniChem include checking whether a standard InChI
in an entry can be converted to a standard InChIKey. If
the entry also includes a standard InChIKey, it is checked
against the standard InChIKey generated from the stan-
dard InChI. Entries that fail these checks are excluded
from the UniChem database as either the standard InChI,
standard InChIKey, or both can then be assumed to be
invalid. In addition to these quality checks, UniChem
keeps track of which database identifiers are currently
associated with a given InChI and which identifiers were
associated with that InChI in the past. It does not output
obsolete associations unless it is requested by the user.
These differences between UniChem and CTS stem
from the fact that they were designed for different pur-
poses. CTS was designed for metabolite annotation and
emphasizes coverage, whereas UniChem was designed
for automatic database cross-referencing and emphasizes
specificity. We include UniChem here to assess the value
of UniChem-like quality checks in metabolite annotation.




The tests described in Methods revealed a number of
differences between the three mapping applications. The
overall performance of each application is quantified in
Table 1. Performance on individual mapping tests is given
in Additional file 1: Table S1. UniChem performed best on
tests involving identifier types that it covered. UniChem
generally only returned the preferred output identifier, for
each input identifier that was associated with at least one
output identifier in the UniChem database. Many input
identifiers, however, were not associated with any output
identifier. This was also the case for CTS, which indicates
that it is a characteristic of InChI based mapping strate-
gies. The fact that no output identifier of a particular type
is returned for a given input identifier does not necessar-
ily mean that the input identifier is not in the database.
It only means that no identifier of the requested output
Table 1 Quantified overall performance of the three
mapping applications
Mean counts
In Hits Out Matches Mean score
MetMask 99 98 146 93 0.63
CTS 99 80 105 75 0.57
UniChem 99 74 77 72 0.70
Scores were calculated as described in Section Scoring. Means were taken over
all input-output pairs that were covered by each application. The means reflect
well general characteristics of each application observed in individual tests (see
Additional file 1: Table S1).
type is associated with the exact same standard InChI. A
single compound can have more than one valid structure,
each represented with a distinct standard InChI. The dis-
tinct, equally valid structures are usually stereoisomers. If
two databases associate different stereoisomers with their
respective entries for the same compound, the two entries
cannot be linked through InChIs. The KEGG Compound
and HMDB entries for lactose are good examples of this
(see Figure 1). Because the lactose stereoisomers in the
two entries have different InChIs, neither UniChem nor
CTS can map between them.
On average, a slightly higher number of input identifiers
were associated with at least one output identifier with
CTS than with UniChem. CTS, however, also returned
a higher number of non-preferred identifiers, and thus
received a lower overall score (Table 1). These differences
between CTS and UniChem are attributable to two fac-
tors; the greater number of identifier types covered by
CTS, and the checks implemented by UniChem to pre-
vent errors in their database (see Section Applications).
The fact that CTS covers chemical names as an identi-
fier type has a particularly large effect. Chemical names
are ambiguous identifiers and the same name can be asso-
ciated with a number of different structures [28]. Using
names as input identifiers will therefore often result in a
long list of candidate output identifiers (see Additional file
1: Table S1). Referring to the previous example, the name
lactose is associated with different structures in KEGG
Compound and HMDB. Inputting the name lactose into
CTS will return all identifiers that are associated with
either structure. The number of incorrect output iden-
tifiers returned for names is also generally higher than
for other input types, because names are more frequently
associated with an incorrect structure [28]. When chemi-
cal name is included as an input identifier type (Figure 2a),
the number of incorrect identifiers returned by CTS is
much greater. When only identifiers that are covered by
UniChem are considered (Figure 2b), CTS results are
more similar to those of UniChem. The remaining differ-
ence between the two applications is presumably due to
the quality checks implemented by UniChem.




Figure 1 Lactose stereoisomers. Two epimers of lactose occur in
nature, α-lactose and β-lactose. The epimers differ by the
configuration of structural groups around a single stereogenic carbon
atom (top right). (a) In KEGG Compound the synonyms lactose and
milk sugar are assigned to a generic stereoisomer, where the
configuration around this stereogenic carbon is not specified
(C00243). Reactions, enzymes and pathways involving lactose are
linked to this entry in KEGG. (b) The same synonyms and most
lactose-related data are linked to the α-epimer in HMDB
(HMDB00186). There is neither an entry for the generic stereoisomer
in HMDB, nor an entry for the α-epimer in KEGG Compound.
MetMask returned the greatest number of preferred
identifiers on average, but it also returned the greatest
number of non-preferred identifiers. It received a score
in between those of UniChem and CTS (Table 1). Met-
Mask returned the greatest number of output identifiers
on individual mapping tests but when all tests were com-
bined, MetMask returned fewer unique identifiers than
CTS (Figure 2). The reason for this is that MetMask gen-
erally returns the same set of output identifiers, when it
is queried with different input identifiers for the same
compound. MetMask will, for example, return the same
set of ChEBI ID whether it is queried with the KEGG
Compound ID (CID) for lactose or the HMDB ID. The
ChEBI ID for both lactose stereoisomers in Figure 1 will be
returned for either query. This is a consequence of the way
metabolite masks are defined. All identifiers for lactose
belong to the same mask. Querying MetMask with any
identifier in a particular mask will always yield all iden-
tifiers of the requested output type that are in the same
mask. Queries with different types of identifiers for the
same compounds are therefore not independent. This also
explains why the difference between the total number of
unique identifiers returned byMetMask, when all tests are
included (Figure 2a) and when only UniChem-compatiple
tests are included (Figure 2b), is so much smaller than for
CTS.
Taken together, these results demonstrate that regard-
less of the choice of mapping application, some manual
effort is required for proper annotation of metabolites
with database identifiers. With MetMask this effort is
mainly directed at sorting through candidate output iden-
tifiers to locate the preferred ones. With UniChem it is
directed at searching for missing identifiers. Some effort
is required for both sorting and gap filling with CTS,
although less for each than with the other two applica-






















Figure 2 Identifiers output in identifier mapping tests. Annotations of unique identifiers returned by each application, (a) when all mapping
tests are included, and (b) when only tests involving identifier types covered by UniChem are included. The output identifiers returned in all
included tests were pooled and duplicates removed. If the same identifier was returned in more than one test it was only counted once. The
annotations are explained in Section Scoring.
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Optimization of performance
In each individual mapping test described in the pre-
vious section, a single identifier was used as input for
each compound. Metabolites in metabolic reconstruc-
tions, however, are often annotated with more than one
identifier, e.g., a name and an HMDB ID. Using all avail-
able identifiers to map to missing ones should be more
powerful than using only one at a time. If one identifier for
a given compound does not map to any identifier of the
requested output type, a different identifier for the same
compound may be used to fill that gap. If multiple identi-
fiers of different types map to the same output identifier,
our confidence in that output identifier is increased. Such
additive mapping of identifiers is only useful, however, if
the different input identifiers do not all yield the same
outputs, i.e., if queries with different input identifiers are
independent. As discussed in the previous section, this is
not the case for MetMask. We therefore only tested this
method on CTS and UniChem.
We investigated the effects of combining outputs for two
to six different types of input identifiers with CTS and two
to four different types of input identifiers with UniChem.
The order, in which input identifiers were added, was
determined based on the numbers of identifiers already
available in Recon 2. All metabolites in Recon 2 have
a name, so we initially used only names. In the second
iteration, we combined outputs for names and standard
InChIKeys, since standard InChIKeys were the second
most common identifier type in Recon 2. In each subse-
quent iteration, we added the next-most-common type of
input identifier until outputs for all input types had been
combined. After each iteration, we assigned a confidence
score to each returned output identifier that was increased
each time that same output identifier was returned. For
each metabolite, we only retained output identifiers with
the highest confidence score out of all identifiers returned
for that same metabolite. The confidence score assigned
to each output identifier was increased by 0.5, if the
identifier was returned with name as the input type and
1 otherwise. Our confidence in identifiers returned for
names was lower than for other identifiers because, as dis-
cussed above, the number of non-preferred and incorrect
identifiers returned for names was higher.
The overall results of each iteration of the additive map-
ping tests are quantified in Table 2. The mean score for
CTS was significantly higher on these tests, than on any
individual mapping test (Table 1). In fact, CTS scored
higher on the additive mapping tests than any of the three
applications did on individual mapping tests, even when
outputs for only two types of input identifiers (names
and standard InChIKeys) were combined. Themean score
for UniChem also increased as input identifiers were
added, although less than for CTS. When multiple input
identifiers were combined, CTS and UniChem received
Table 2 Quantified overall performance of CTS and
UniChem on the additive identifier mapping tests
Mean counts
In Hits Out Matches Mean
score
Name only
CTS 100 67 141 63 0.30
UniChem NA NA NA NA NA
+ InChIKey
CTS 100 95 112 87 0.
UniChem 100 80 83 78 0.75
+ ChEBI
CTS 100 96 118 93 0.75
UniChem 100 84 88 82 0.78
+ HMDB
CTS 100 96 113 89 0.75
UniChem 100 85 88 82 0.79
+ KEGG
CTS 100 97 116 93 0.78
UniChem 100 87 91 85 0.82
+ PubChem
CTS 100 97 117 94 0.78
UniChem NA NA NA NA NA
Results of individual tests are given in Additional file 1: Table S2. NA implies that
the input identifier type was not covered by the corresponding application.
PubChem refers to the PubChem Compound database and KEGG to the KEGG
Compound database.
similar scores, but for different reasons. UniChem con-
tinued to return only the preferred output identifier for
most metabolites but, even with four input identifier types
combined, it did not return an output identifier for all
metabolites. CTS, on the other hand, returned at least one
candidate output identifier for most metabolites. The pre-
ferred identifier was generally amongst those candidates
but several non-preferred identifiers were also returned.
In our opinion, the results of combining input identi-
fiers were qualitatively better for CTS than for UniChem.
Despite the fact that somemanual effort is required to sort
through candidate output identifiers returned by CTS, it
is reassuring to know that the output is relatively com-
prehensive. Otherwise, it would be necessary to search
manually for identifiers that may not even exist. Accepting
and rejecting suggested identifiers is fast by compari-
son. In the following section, we therefore use additive
mapping with CTS to update metabolite annotations in
Recon 2 [23].
Update of Recon 2metabolite annotations
Recon 2 includes 2,626 unique metabolites. During the
reconstruction of Recon 2, 1,690 metabolites were anno-
tated with a standard InChIKey, 1,125 with a ChEBI ID,
1,040 with an HMDB ID, 396 with a KEGG CID, and
150 with a PubChem CID. All metabolites were anno-
tated with a metabolite name. We updated metabolite
identifiers in Recon 2 using additive mapping with CTS
as described in the previous section. We used CTS both
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to review existing annotations and to add as many new
ones as possible. In addition to updating identifier types
that were already present in Recon 2, we added identi-
fiers for the LIPID MAPS Structure Database (LMSD)
[32] which were previously missing. To speed up the
process of updating identifiers, we took advantage of
the extensive metabolite annotations that are available in
HMDB [14,15]. The step-by-step process is described in
Additional file 1: Section 2. We added a total of 3,049
new identifiers to Recon 2, removed 124 incorrect identi-
fiers, and replaced 569 identifiers. We therefore updated
a total of 3,746 identifiers. All except 233 identifiers
were updated automatically. These 233 identifiers were
selected manually from a list of 2,790 candidates that were
returned by CTS.Manually sorting through the list of can-
didates required approximately ten man-hours. A random
sample of 100 automatically updated identifiers were also
checked manually. All 100 were found to be correct. The
full list of updated metabolite annotations in Recon 2 is
included in the Additional file 2.
The majority (1,962/2,660) of added identifiers were
KEGG and PubChem CID (Figure 3a), which were previ-
ously lacking in Recon 2. We also added LMSD ID for 389
metabolites. Around half (65/124) of all incorrect identi-
fiers were PubChem CID. The remaining half was evenly
distributed among ChEBI ID, HMDB ID and KEGG CID.
Incorrect identifiers were identified and removed auto-
matically (see Additional file 1: Section 2). The majority
of replaced identifiers (464/569) were ChEBI ID. In most
cases, we replaced a ChEBI ID for a charged metabolite,
with a ChEBI ID for the same metabolite in its neu-
tral state. ChEBI and PubChem Compound often include
separate entries for metabolites in neutral and various
charged states, but HMDB , KEGGCompound and LMSD
usually only include metabolites in their neutral state.
For the sake of mapping and other comparisons between
databases, it is therefore preferable to include identi-
fiers for metabolites in their neutral states in metabolic
reconstructions. If metabolite charge is required, it can
be predicted with software tools, such as ChemAxon’s
Calculator Plugins (ChemAxon Kft., Budapest, Hungary).
Most of the added identifiers (2,991/3,049) were for
metabolites that were already annotated with at least one
identifier besides a chemical name in Recon 2 (Figure 3b).
Non-name identifiers were added for 28 metabolites that
were previously only annotated with a name. That leaves
594 Recon 2 metabolites with name as the only annota-
tion. There are two possible reasons for this; either these
metabolites are not included in the CTS database, or the
synonyms used for them in Recon 2 is not included. The
CTS name search is currently only capable of match-
ing names exactly, so even slight differences between a
metabolite name in Recon 2 and the synonyms listed for
that metabolite in CTS would prevent finding a match.
A majority (432/594) of the metabolites for which no
identifier was found consisted of macromolecules and
metabolites with variable structures (i.e., R groups), such
as polysaccharides and proteins. Such metabolites are sel-
dom included in the chemical databases considered here,
so it is not surprising that no identifiers were found. In
addition, metabolites with variable structures cannot be
represented with an InChI. An InChI based application
such as CTS therefore cannot cover them. The remaining
metabolites (162/594) are more likely to be included in the
databases considered here. If they are, they must be regis-
tered under different synonyms than the names included
in Recon 2. Non-name identifiers for these metabolites
will need to be searched for manually.
Discussion
The three applications compared in this work implement
two different metabolite annotation strategies. MetMask
implements what can be termed a “metabolite mask-
ing” strategy (see Section MetMask), whereas CTS and
UniChem implement two different versions of an InChI
based strategy (see Sections The Chemical Translation
System and UniChem). We found the InChI based strat-
egy to be better suited for annotation of metabolites





















Figure 3 Recon 2 identifiers. Identifier statistics for Recon 2 before and after metabolite annotations were updated with CTS. (a) Number of
unique metabolites with each of the seven types of identifiers. n: names, i: InChIKeys, c: ChEBI ID, h: HMDB ID, k: KEGG CID, p: PubChem CID, l:
LipidMAPS ID. (b) Number of unique metabolites with one, and up to seven, identifiers each.
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in genome-scale metabolic reconstructions. The main
advantage of this strategy over the metabolite masking
strategy is that multiple types of information about a
metabolite can be used to perform independent searches
for missing annotations. The independent search results
can then be combined to increase both coverage and
specificity. Candidate annotations are thereby found for
a greater number of metabolites (increased coverage),
while candidate annotations for each metabolite are fewer
and usually include the preferred annotations (increased
specificity). Candidate annotations, which are returned
by multiple independent searches, can additionally be
assigned in an automatic manner with more confidence.
Neither the CTS nor UniChem user interfaces currently
offer the possibility of combining multiple types of
information to search for missing annotations. Here we
performed each search separately and combined results
afterwards. This process was slow and required a consid-
erable amount of programming. An InChI based applica-
tion that allows simultaneous input of multiple types of
metabolite information would greatly simplify and accel-
erate annotation.
When multiple independent search results were com-
bined, the InChI based strategy implemented in CTS
gave qualitatively better results than the version imple-
mented in UniChem. Although UniChem gave more specific
results, CTS covered a greater number of metabolites.
The main advantage of CTS over UniChem is that it
can map between a greater number of identifier types.
We chose to map between a limited number of identifier
types, that are relevant for the human metabolic recon-
struction Recon 2, but the same strategy could be used to
map between any of the 215 types of identifiers covered by
CTS.
The greater metabolite coverage of CTS was mostly due
to the fact that CTS allows chemical names as inputs.
This was also the main reason for the lower specificity of
CTS results. Chemical names are rather generic metabo-
lite identifiers, or at least they are used rather generically
in chemical databases. The same name is often associated
with multiple different structures, sometimes incorrectly
[28]. When names are input to an InChI based map-
ping application, identifiers for different but equally valid
structures may be returned leading to increased cov-
erage. However, identifiers for nonpreferred, invalid or
even incorrect structures may also be returned leading to
reduced specificity. Inputting the name lactose to CTS, for
example, will return both a KEGG CID and an HMDB ID,
for different but equally valid lactose stereoisomers (see
Figure 1). However, it will also return a total of four Pub-
Chem CID, one of which is invalid as it refers to a generic
disaccharide (PubChem CID 294). To retain the coverage
obtained with chemical names as inputs, while minimiz-
ing the adverse effects it has on specificity, we introduced
a confidence score that gave annotations returned for
names a lower priority. A similar mechanism could be
built into the metabolite annotation application suggested
above, where multiple types of metabolite information
could be input simultaneously as search criteria.
Although the fact that CTS allows names as inputs
explains most of the difference between the specificity
of CTS and UniChem, it does not explain all of it (see
Figure 2 and Additional file 1: Table S1). Some of this dif-
ference is also due to the quality checks performed by
UniChem before data from external databases is imported
into the UniChem database (see Section UniChem). Any
InChI based application would benefit from similar qual-
ity checks. A recent study [33] showed that different struc-
tural representations (Molfiles, InChIs, SMILES) within
the same database entry often do not represent the same
structure. Such mismatches are indicative of errors in
database entries. Quality checks such as the ones imple-
mented in UniChem hinder such errors from being prop-
agated to local databases for annotation applications.
Additional quality checks could also be performed, such
as checking whether the two dimensional structure (e.g.,
in Molfile format) and the chemical formula in an exter-
nal database entry match the standard InChI. Chemical
formulas can also be used to check candidate annota-
tions returned for metabolites and to weed out incorrect
ones. All metabolites in metabolic network reconstruc-
tions should be annotated with their chemical formu-
las. We used metabolite formulas in Recon 2 to review
database identifiers that were added to the reconstruc-
tion (see Additional file 1: Section 2). If the metabolite
formula in the database entry associated with an identi-
fier did not match the formula in Recon 2, we assumed
the identifier was incorrect and rejected it. Differences
in numbers of hydrogen atoms between formulas were
ignored. The metabolite annotation application suggested
above could include metabolite formulas as one type of
input information about metabolites. Candidate identi-
fiers associated with different formulas than the input for-
mula would then be rejected before they were added to the
reconstruction.
The coverage of any InChI based application is lim-
ited to metabolites with defined structures that can be
represented with InChIs. Metabolic reconstructions often
include generic metabolites with undefined structural ele-
ments such as R groups. These generic metabolites rep-
resent whole classes of structurally similar metabolites
that undergo the same metabolic transformations in vivo.
They are introduced into reconstructions for simplifi-
cation. Such generic metabolites cannot be represented
with an InChI and therefore cannot be covered by an
InChI based metabolite annotation application. An anno-
tation application based on a metabolite masking strategy
would be better suited to mapping between identifiers for
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such metabolites. The fact that an InChI based applica-
tion cannot cover generic metabolites of this type does
not decrease its value much, since these metabolites are
generally a minority of all metabolites in metabolic recon-
structions and only a minority of those is expected to be
included in chemical databases of interest.
Generic metabolites of a different type that are also
found in metabolic reconstructions are generic stereoiso-
mers, i.e., metabolites with undefined stereochemistry at
one or more stereocenters. An example found in Recon 2
is lactose in Figure 1a. As enzymes that catalyze metabolic
reactions involving lactose generally don’t have known
stereospecificity, both the α- and β-epimers are assumed
to participate in the same reactions. Instead of needlessly
complicating the reconstruction by writing the same reac-
tions twice, the two epimers are collapsed into a single
generic stereoisomer. The metabolic component lactose
in Recon 2 therefore encompasses both α- and β-lactose.
Similar examples are frequent in fatty acid metabolism
where cis-trans isomerism is not specified unless neces-
sary, i.e., for fatty acids that participate in reactions that
are catalyzed by enzymes with known stereospecificity.
Generic stereoisomers can be represented with an
InChI and can therefore be covered by an InChI based
application. CTS often returned several candidate iden-
tifiers for such metabolites that needed to be sorted
through manually to select the preferred ones. One rea-
son for this is that the names of generic stereoisomers
in Recon 2 are often associated with more specific or
even more generic (and thus invalid) stereoisomers in the
databases considered here. As discussed above, the name
lactose is associated with α-lactose (more specific) in
HMDB and a disaccharide with no specified stereochem-
istry (more generic) in PubChem among other database
identifiers. Another reason for why CTS often returned
several candidate identifiers for generic stereoisomers was
that preexisting annotations of these metabolites in Recon
2 were sometimes rather ambiguous. Lactose in Recon
2, for example, was annotated with the KEGG CID for
the generic stereoisomer (Figure 1a) and the HMDB ID
for the α-epimer (Figure 1b). When these two identifiers
were used in combination to find the PubChem CID for
lactose, CTS naturally returned PubChem CID for both
stereoisomers. This raises the question of how generic
stereoisomers should be annotated in metabolic recon-
structions. The general rule should be to annotate each
metabolite with the most generic identifier of each type
that is still valid. Lactose therefore should be annotated
with identifiers for the generic stereoisomer in Figure 1a.
However, there is no entry for this lactose stereoisomer
in HMDB. Instead, HMDB includes separate entries for
the more specific α- and β-epimers of lactose. In such
cases, the general rule in the past appears to have been
to select the identifier for the most prevalent specific
stereoisomer, e.g., the HMDB ID for α-lactose, as rel-
evant biochemical data is more likely to be associated
with that identifier. The advantage of annotating generic
stereoisomers with identifiers for more specific ones is
precisely that they provide links to such data. The dis-
advantage is that the identity of metabolic components
becomes somewhat ambiguous. It may, for example, not
be obvious to all users of Recon 2 whether the metabolic
component lactose represents the generic stereoisomer or
only α-lactose since it is annotated with identifiers for
both.
Reconstruction of the metabolic network of an organ-
ism or cell type is an iterative process. Recon 2 is the
latest iteration of the human metabolic network recon-
struction. While Recon 2 is much more comprehen-
sive than its predecessor Recon 1 [34], it probably does
not capture the entire human metabolic network and
further iterations are expected in the future [23]. Our
results suggest some guidelines for researchers to keep in
mind when annotating new metabolites that are added to
metabolic reconstructions, human or otherwise. Firstly,
each metabolite should be annotated with at least one
identifier besides name if that is possible. Secondly, each
metabolite should generally be annotated with identifiers
for its neutral form. Exceptions exist for metabolites that
only participate in metabolic reactions in a particular
charged state, e.g. inorganic ions such as Cl− and Mg2+.
Thirdly, each metabolite should preferably be annotated
with the most generic identifier of each type that is still
valid. This also applies to metabolite names. The name D-
glucose, for example, should not be used for a metabolic
component that is meant to represent α-D-glucose or
vice versa. If no generic identifier of a particular type
is available for a metabolite, a more specific identifier
may be used. Researchers should, however, be aware that
doing so makes the identity of that metabolite somewhat
ambiguous. Best practices would be to include a note that
specifies the relationship of an identifier to a metabolic
component. The ChEBI ontology could serve as a guide-
line for how relationships between metabolites should be
specified. So, for example, it would be noted that the
metabolite with HMDB ID HMDB00186 (Figure 1b) is a
Lactose.
An InChI based metabolite annotation application
has the potential to enable fully automatic mapping
between identifiers for metabolites with defined struc-
tures. Fully automatic mapping, however, would require
that both databases and reconstructions were free of
errors and ambiguity. As several authors have demon-
strated [28,33,35], errors and ambiguities are quite com-
mon in publicly available chemical databases. If a database
identifier is associated with an incorrect InChI in a
database it will not be mapped to the correct metabolite
in a reconstruction. As we demonstrated here, erroneous
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metabolite annotations are also found in metabolic
reconstructions. In particular, we removed 124 incorrect
identifiers from Recon 2. As discussed above metabo-
lite annotations in metabolic reconstructions can also be
ambiguous, e.g., when a metabolite is annotated with the
name of one stereoisomer but the KEGG CID of another.
If a metabolite is annotated with an incorrect identifier
in a metabolic reconstruction it may not be mapped to
the correct database or structure based identifier. Fully
automatic mapping between metabolite identifiers will
not be possible until such errors and ambiguities are
resolved. An InChI based application such as CTS, how-
ever, with the modifications suggested above, can signif-
icantly reduce the manual effort required for mapping
between metabolite identifiers.
Experimental
CTS was accessed by calling the “Convert” web ser-
vice as described at http://cts.fiehnlab.ucdavis.edu/
moreServices/index. UniChem was accessed by calling
the web service method "Get src_compound_ids from
src_compound_id" as described at https://www.ebi.ac.
uk/unichem/info/webservices. Web services were called
from MATLAB (version R2009b, MathWorks, Natick,
MA) using the built-in function urlread. MetMask (ver-
sion 0.5.3) was installed on a desktop computer running
Windows 7. MetMask databases were created by import-
ing identifier groups from Recon 2, HMDB and ChEBI.
Database queries were formulated as described at http://
metmask.sourceforge.net/manual.html with all options
set to their default values. Output from all mapping
applications was parsed in MATLAB using the built-in
function regexp.
Conclusions
We found that an application implementing an InChI
based strategy could facilitate automatic mapping
between metabolite identifiers in metabolic network
reconstructions. Of the two InChI based applications
evaluated here we found CTS to be qualitatively better.
The main advantage of CTS is the large number of iden-
tifier types it can map between. As CTS is open source it
can be adapted to the task of mapping betweenmetabolite
identifiers in metabolic network reconstructions with rel-
ative ease.We suggest several features that could be added
to CTS to optimize its performance on this task. In partic-
ular, we suggest combining multiple types of information
about metabolites to find new identifiers. A confidence
score can be used to account for the fact that some types
of input information, in particular metabolite names, are
less reliable than others. We further suggest implement-
ing various quality checks, similar to those implemented
in UniChem, to limit the number of incorrect identifiers
returned for a metabolite. When simple versions of some
of the suggested features were implemented, CTS allowed
us to update more than 3,500 metabolite identifiers in
Recon 2. Most were updated automatically. Based on
this experience, we suggest some guidelines for future
annotation of metabolites in metabolic network recon-
structions. We hope that the updated Recon 2 identifiers
will facilitate application of Recon 2 in the future. More
generally, we hope that our results will guide developers
of reconstruction tools in implementing strategies for
automatically updating metabolite identifiers in metabolic
network reconstructions.
Methods
Design of identifier mapping tests
MetMask and CTS were tested by mapping six types of
input identifiers to four types of output identifiers. The
six input identifier types were metabolite name, stan-





Figure 4 Annotation of output identifiers. An example
demonstrating annotation of output PubChem Compound identifiers
(b-e), when the KEGG Compound identifier for D-glucose (a) is input
to a mapping application. The preferred output identifier is for
D-glucose (b), but an identifier for alpha-D-glucose (c) is also valid
since it is a D-glucose. An identifier for a generic hexose (d), however,
is not valid. Finally, an identifier for phospholactic acid (e), which is a
completely different compound, is incorrect.
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PubChem CID. Output identifier types were the subset of
input types that act as primary keys in public databases,
i.e., ChEBI ID, HMDB ID, KEGG CID and PubChem CID.
Output identifiers of these four types can easily be veri-
fied by looking them up in the relevant databases. Since
metabolite names and InChIKeys aremore difficult to ver-
ify, they were not included as output identifier types. In
total, we tested MetMask and CTS on 20 pairs of input-
output identifier types, since input identifiers were not
mapped to output identifiers of the same type. ChEBI ID
for example, were only mapped to HMDB ID, KEGG CID
and PubChem CID. UniChem was tested on nine input-
output pairs, since it does not cover metabolite names or
PubChem CID. All three applications were tested on a
set of 100 metabolites from the human metabolic recon-
struction Recon 2 [23]. The metabolites were chosen ran-
domly from the subset of Recon 2 metabolites that were
already annotated with at least two of the four database
identifiers. For each metabolite, we verified the existing
annotations and attempted to fill in missing annotations
of the remaining four input types. The end result was
100 metabolite names, 100 InChIKeys, 98 ChEBI ID, 100
HMDB ID, 97 KEGG CID and 100 PubChem CID. A min-
imum of five identifiers were located for each of the 100
test metabolites.
Scoring
To quantify the relative performance of the three map-
ping applications, we devised a simple scoring system.
For each input-output pair, each mapping application
returned a list of candidate output identifiers associ-
ated with the set of input identifiers. The number of
output identifiers associated with a single input iden-
tifier ranged from zero to several. We annotated each
returned output identifier as preferred, valid, invalid,
incorrect or nonexistent (see Figure 4 for an example).
Preferred identifiers point to the preferred stereoisomer
of each compound, which is generally the same as the
input stereoisomer. There is exactly one preferred output
identifier for each input identifier. Valid identifiers point
to valid but not preferred stereoisomers, invalid identi-
fiers point to invalid stereoisomers or mixtures, incorrect
identifiers point to different compounds, and nonexis-
tent identifiers do not point to anything. Once all output
identifiers had been annotated in this manner, we calcu-
lated a score based on the number of input identifiers
(In), the number of input identifiers for which at least
one output identifier was returned (Hits), the total num-
ber of returned output identifiers (Out), and the number
of preferred output identifiers (Matches). The score was
calculated as
Score = Hits × MatchesIn × Out . (1)
This score can range from 0 to 1. An application receives
themaximum score if it returns the preferred output iden-
tifier, and no other, for each input identifier. It receives
a lower score if it returns non-preferred identifiers, or
none at all, for a subset of input identifiers, since some
manual effort is then required to sort through results and
fill gaps. Note that the number of input identifiers (In)
varies between identifier types, because two of the 100 test
metabolites were not found in ChEBI (In = 98) and three
were not found in KEGG Compound (In = 97).
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